MaxCyte STX®

MaxCyte STX®


Contact us for more information.

The MaxCyte STX® Scalable Transfection System uses Flow Electroporation Technology for rapid, high-performance engineering of cells for a broad array of applications. It addresses the R&D arena from early-stage development through pre-clinical work, including toxicology studies. Use the MaxCyte STX to improve the quality and time-to-market of your vaccines, small molecule drugs and biotherapeutics candidates.


  • Cell viabilities >90% for commonly used cell types
  • Transfection efficiencies >90%
  • Computer-controlled system for day-to-day and user-to-user consistency


  • Engineer cell lines, primary cells and difficult-to-transfect cells
  • Single animal component-free electroporation buffer for all cell types
  • Pre-loaded library of validated, cell specific protocols for plug-and-play transfection


  • 5 x 106 to 7 x 108 cells in seconds
  • Up to 2 x 1010 cells in <30 minutes


  • Sterile, single use processing assemblies
  • Closed, cGMP-compliant, ISO-certified and CE-marked instruments
  • Supported by FDA master file

Scale up on the MaxCyte STX Requires No Re-optimization